catalyst

A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cog — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2019-10-21 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cog — primary completion
Type
Trial Readout
Date
2019-10-21
Date type
ACTUAL
Phase
Phase 2
This event happened.
relationships
The graph out of here
trial
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
trial